Chester County News and Community Website
MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH), one of the world’s largest manufacturers of discrete semiconductors and passive components, announced that the Company’s Board of Directors declared a dividend …
Read More
MALVERN, PA — CubeSmart (NYSE: CUBE) a self-administered and self-managed real estate investment trust focused on self-storage properties, announced that its Board of Trustees declared a quarterly dividend of $0.33 …
Read More
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) announced that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock.
Read More
VALLEY FORGE, PA — The Board of Directors of UGI Corporation (NYSE: UGI) has declared a quarterly dividend of $0.33 per share of the company’s common stock. The dividend is …
Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage company focused on discovering, developing and commercializing transformative therapies to treat rare and underserved ophthalmic diseases, announced the amendment and exchange …
Read More
EXTON, PA — Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) announced entering into an agreement with a fund affiliated with an institutional investor providing for a private placement exempt from the registration …
Read More
MALVERN, PA — Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced that the Compensation Committee of Baudax Bio’s Board of Directors approved …
Read More
EXTON, PA — Omega Flex, Inc. (NASDAQ: OFLX) announced that the Board of Directors declared a regular quarterly dividend of $0.28 per share payable on April 17, 2020 to shareholders …
Read More
MALVERN, PA — Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced the closing of the previously announced public offering, reflective of …
Read More
MALVERN, PA — Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced the pricing of an underwritten public offering of 7,692,308 shares …
Read More